Edition:
India

GBT Posts Quarterly Loss Per Share Of $1.59


Thursday, 27 Feb 2020 

Feb 26 (Reuters) - Global Blood Therapeutics Inc ::GBT REPORTS RECENT BUSINESS PROGRESS AND FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS.Q4 LOSS PER SHARE $1.59.Q4 EARNINGS PER SHARE ESTIMATE $-1.24 -- REFINITIV IBES DATA.TOTAL PRODUCT SALES, NET FOR Q4 OF 2019 WAS $2.1 MILLION, DRIVEN BY INITIAL SALES OF OXBRYTA.GLOBAL BLOOD THERAPEUTICS- CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES TOTALED $695.0 MILLION AT DEC 31, 2019, COMPARED WITH $591.8 MILLION AT DEC 31, 2018.